Tirzepatide + B6 BPI

Tirzepatide Injections are subcutaneous dual GIP/GLP-1 receptor agonist injections that may support glycemic control and weight management if prescribed after clinician evaluation. Each dose is administered as a small subcutaneous injection as directed. A licensed clinician will determine suitability and dosing, provide training on preparation and injection technique, review storage, and schedule follow-up. Use only as prescribed; individual results and timelines vary. Rx only, if prescribed after medical review. May be dispensed as a brand or, where permitted, as a compounded product; compounded versions are not FDA-approved and not evaluated by the FDA for safety or effectiveness. Not for patients with a personal/family history of medullary thyroid carcinoma or MEN2; your provider will review risks (including GI effects and rare pancreatitis).